Bonesupport Holding AB (BONEX)

Currency in SEK
217.40
-9.00(-3.98%)
Closed·
BONEX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
216.20225.80
52 wk Range
165.00346.40
Key Statistics
Prev. Close
217.4
Open
225.8
Day's Range
216.2-225.8
52 wk Range
165-346.4
Volume
360.76K
Average Volume (3m)
342.14K
1-Year Change
-27.291%
Book Value / Share
14.26
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BONEX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
377.17
Upside
+73.49%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Bonesupport Holding AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also offers CERAMENT Bead Tray, an adjunctive local delivery option for surgeons for targeted delivery to osseous defects and for dead space management. In addition, the company develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, and foot and ankle surgery. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Employees
160
Market
Sweden

Bonesupport Holding AB Earnings Call Summary for Q2/2025

  • Net sales up 29% YoY (40% in constant currency) to SEK 284M; CERAMENT G U.S. sales surge 84%, totaling SEK 1B since launch
  • Operating result (ex-incentives) SEK 62M; reported EBIT SEK 55M; operating cash flow SEK 50M; gross margin 95% in Europe/RoW
  • Forecasts sales growth above 40% in constant currency for full year; CERAMENT BVF Spine launch planned for December 2025
  • Exploring joint infection prevention market; considering price increases; awaiting FDA approval for CERAMENT V launch in H1 2026
  • Strong financial health: 92.59% gross profit margin, 44.52% revenue growth (LTM), 4.34 current ratio, 0.02 debt-to-equity ratio
Last Updated: 14/10/2025, 16:54
Read Full Transcript

Compare BONEX to Peers and Sector

Metrics to compare
BONEX
Peers
Sector
Relationship
P/E Ratio
79.3x−2.8x−0.5x
PEG Ratio
1.53−0.080.00
Price/Book
15.6x1.4x2.6x
Price / LTM Sales
12.1x1.8x3.2x
Upside (Analyst Target)
75.9%101.5%48.8%
Fair Value Upside
Unlock29.2%7.6%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 377.17
(+73.49% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
22/04/2026
EPS / Forecast
0.81 / 0.98
Revenue / Forecast
324M / 335.2M
EPS Revisions
Last 90 days

People Also Watch

525.00
CAMX
-2.33%
151.00
ALIFb
-0.59%
176.75
MILDEF
-3.99%
192.8000
MTRS
-2.16%
234.20
LAGRb
-1.01%

FAQ

What Is the Bonesupport (Stockholm: BONEX) Share Price Today?

The Bonesupport stock price today is 217.40 SEK.

What Stock Exchange Does Bonesupport (BONEX) Trade On?

Bonesupport is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Bonesupport?

The stock symbol (also called a 'ticker') for Bonesupport is "BONEX."

What Is the Current Bonesupport Market Capitalisation?

As of today, Bonesupport (Stockholm: BONEX) market cap is 14.32B SEK.

What Is Bonesupport's (BONEX) Earnings Per Share (TTM)?

The Bonesupport EPS is currently 2.77 (Trailing Twelve Months).

When Is the Next Bonesupport Earnings Date?

Bonesupport's next earnings report will be released on 16/07/2026.

Is BONEX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bonesupport moving averages and other technical indicators, the daily buy/sell signal for BONEX stock is Strong Sell.

How Many Times Has Bonesupport Stock Split?

Bonesupport has split 0 times. (See the BONEX stock split history page for full effective split date and price information.)

How Many Employees Does Bonesupport Have?

Bonesupport has 160 employees, based on their latest Companies House report.

What is the current trading status of Bonesupport (Stockholm: BONEX)?

As of 29/04/2026, Bonesupport (BONEX) is trading at a share price of 217.40 SEK, with a previous close of 217.40 SEK. The stock has fluctuated within a day range of 216.20 SEK to 225.80 SEK, while its 52-week range spans from 165.00 SEK to 346.40 SEK.

What Is Bonesupport (BONEX) Price Target According to Analysts?

The average 12-month price target for Bonesupport is 377.17 SEK, with a high estimate of 428 SEK and a low estimate of 320 SEK. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +73.49% Upside potential.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.